New Update
/anm-english/media/post_banners/5Hn1a2TDtIxHQsXZDq50.jpg)
By Our Staff Reporter: Following are key excerpts from an exchange filing by Caplin Point Laboratories Ltd today:
* Subsidiary Caplin Steriles Ltd has received the approval of Brazil's National Health Surveillance Agency ANVISA (Agencia Nacional de Vigilancia Sanitaria) for its sterile injectable manufacturing site near Chennai in Tamil Nadu
* The approval grants access to the company to register and market its products in Brazil
/anm-english/media/agency_attachments/AtBG5e3MoE629QYzhZen.png)